课题基金 / 基金详情

Developing radioimmunotherapy of osteosarcoma using comparative oncology approach

Developing radioimmunotherapy of osteosarcoma using comparative oncology approach
使用比较肿瘤学方法开发骨肉瘤的放射免疫疗法
批准号：
389648
负责人：
Dadachova Ekaterina
金额：
$55.73万
依托单位：
University of Saskatchewan
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-09-01 至 2023-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=389648&lang=en
关键词：
177lutetium Companion Dogs With Osterosarcoma Human Antibodies Immunohistochemistry Insulin Growth Factor Type 2 Receptor Mouse Models Non-Invasive Pet And Spect/Ct Imaging Ostersarcoma Radioimmunotherapy Safety Studies

项目摘要

项目成果

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Osteosarcoma (OS) is the most common primary malignant bone tumor and the fifth most common primary malignancy among adolescents and young adults. Unfortunately, overall survival is approximately 70%, with no meaningful improvement realized in over 20 ye
期刊论文(0)
专著(0)
科研奖励(0)
会议论文